In conclusion, inhibition of NF-κB in macrophages by SKLB023 ameliorated the joint inflammation and cartilage destruction in the progression of RA, and it serves as a novel therapeutic strategy for rheumatoid arthritis. The gene discussed is NFKB1; the disease is rheumatoid arthritis.